Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy"

Eur J Neurol. 2026 Jan;33(1):e70470. doi: 10.1111/ene.70470.
No abstract available

Publication types

  • Letter